1, 3, 4‐oxadiazole derivatives as potential antimicrobial agents. (27th June 2022)
- Record Type:
- Journal Article
- Title:
- 1, 3, 4‐oxadiazole derivatives as potential antimicrobial agents. (27th June 2022)
- Main Title:
- 1, 3, 4‐oxadiazole derivatives as potential antimicrobial agents
- Authors:
- Tiwari, Deeksha
Narang, Rakesh
Sudhakar, Kalvatala
Singh, Vikramjeet
Lal, Sukhbir
Devgun, Manish - Abstract:
- Abstract: Due to the emergence of drug‐resistant microbial strains, different research groups are continuously developing novel drug molecules against already exploited and unexploited targets. 1, 3, 4‐Oxadiazole derivatives exhibited noteworthy antimicrobial activities. The presence of 1, 3, 4‐oxadiazole moiety in antimicrobial agents can modify their polarity and flexibility, which significantly improves biological activities due to various bonded and non‐bonded interactions viz. hydrogen bond, steric, electrostatic, and hydrophobic with target sites. The present review elaborates the therapeutic targets and mode of interaction of 1, 3, 4‐oxadiazoles as antimicrobial agents. 1, 3, 4‐oxadiazole derivatives target enoyl reductase (InhA), 14α‐demethylase in the mycobacterial cell; GlcN‐6‐P synthase, thymidylate synthase, peptide deformylase, RNA polymerase, dehydrosqualene synthase in bacterial strains; ergosterol biosynthesis pathway, P450‐14α demethylase, protein‐N‐myristoyltransferase in fungal strains; FtsZ protein, interfere with purine and functional protein synthesis in plant bacteria. The present review also summarizes the effect of different moieties and functional groups on the antimicrobial activity of 1, 3, 4‐oxadiazole derivatives. Abstract : 1, 3, 4‐oxadiazole derivatives can target enoyl reductase, 14‐α‐demethylase in the mycobacterial cell; GlcN‐6‐P synthase, thymidylate synthase, biofilm, peptide deformylase, RNA polymerase, dehydrosqualene synthase inAbstract: Due to the emergence of drug‐resistant microbial strains, different research groups are continuously developing novel drug molecules against already exploited and unexploited targets. 1, 3, 4‐Oxadiazole derivatives exhibited noteworthy antimicrobial activities. The presence of 1, 3, 4‐oxadiazole moiety in antimicrobial agents can modify their polarity and flexibility, which significantly improves biological activities due to various bonded and non‐bonded interactions viz. hydrogen bond, steric, electrostatic, and hydrophobic with target sites. The present review elaborates the therapeutic targets and mode of interaction of 1, 3, 4‐oxadiazoles as antimicrobial agents. 1, 3, 4‐oxadiazole derivatives target enoyl reductase (InhA), 14α‐demethylase in the mycobacterial cell; GlcN‐6‐P synthase, thymidylate synthase, peptide deformylase, RNA polymerase, dehydrosqualene synthase in bacterial strains; ergosterol biosynthesis pathway, P450‐14α demethylase, protein‐N‐myristoyltransferase in fungal strains; FtsZ protein, interfere with purine and functional protein synthesis in plant bacteria. The present review also summarizes the effect of different moieties and functional groups on the antimicrobial activity of 1, 3, 4‐oxadiazole derivatives. Abstract : 1, 3, 4‐oxadiazole derivatives can target enoyl reductase, 14‐α‐demethylase in the mycobacterial cell; GlcN‐6‐P synthase, thymidylate synthase, biofilm, peptide deformylase, RNA polymerase, dehydrosqualene synthase in bacterial strains; ergosterol biosynthesis pathway, P−450‐14α demethylase in fungal strains. 1, 3, 4‐Oxadiazole derivatives also exhibited insecticidal activities against plant pathogens by interfering with the functioning of ribosomes. The effect of various substituents attached to 1, 3, 4‐oxadiazole derivatives on different antimicrobial activities has been analyzed. … (more)
- Is Part Of:
- Chemical biology & drug design. Volume 100:Number 6(2022)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 100:Number 6(2022)
- Issue Display:
- Volume 100, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 100
- Issue:
- 6
- Issue Sort Value:
- 2022-0100-0006-0000
- Page Start:
- 1086
- Page End:
- 1121
- Publication Date:
- 2022-06-27
- Subjects:
- 1, 3, 4‐Oxadiazole derivatives -- 3D‐QSAR -- antimicrobial -- molecular docking -- structure–activity relationship -- therapeutic targets
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.14100 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24621.xml